CompletedPhase 2NCT03871361

Abatacept in Patients With Birdshot HLA A29 Uveitis

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universitaire Ziekenhuizen KU Leuven
Principal Investigator
Pieter-Paul FA Schauwvlieghe, MD
Universitaire Ziekenhuizen KU Leuven
Intervention
Abatacept 125 MG/ML Prefilled Syringe(drug)
Enrollment
15 target
Eligibility
18 years · All sexes
Timeline
20192023

Study locations (1)

Collaborators

Ziekenhuis Netwerk Antwerpen (ZNA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03871361 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials